Proton therapy for early-stage non-small cell lung cancer (NSCLC).

about

Proton therapy for early-stage non-small cell lung cancer (NSCLC).

Item

http://www.wikidata.org/entity/Q55208073

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Proton therapy for early-stage non-small cell lung cancer (NSCLC).

@en

Proton therapy for early-stage non-small cell lung cancer

@nl

type

Item

label

Proton therapy for early-stage non-small cell lung cancer (NSCLC).

@en

Proton therapy for early-stage non-small cell lung cancer

@nl

prefLabel

Proton therapy for early-stage non-small cell lung cancer (NSCLC).

@en

Proton therapy for early-stage non-small cell lung cancer

@nl

P1476

Proton therapy for early-stage non-small cell lung cancer (NSCLC).

@en

P2093

Daniel R Gomez

http://www.w3.org/2001/XMLSchema#string

Heng Li

http://www.w3.org/2001/XMLSchema#string

Joe Y Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy.

Clinical implementation of intensity modulated proton therapy for thoracic malignancies.

Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.

Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.

Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.

Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

P304

199-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TLCR.2018.04.12

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29876319

http://www.w3.org/2001/XMLSchema#string

P932

5960659

http://www.w3.org/2001/XMLSchema#string